Involvement of RIPk4 in melanoma malignacy regulated by Wnt/b-catenin signaling.

2018/31/B/NZ5/01423

Keywords

Descriptors

  • NZ1_2: Biochemia
  • NZ3_7: Przekaźnictwo sygnału
  • NZ5_7: Leczenie chorób człowieka

Panel

NZ5 – Human and animal noninfectious diseases: etiology, mechanisms, diagnosis and treatment of diseases, poisonings and injuries (without neurological diseases)

Host institution

Uniwersytet Jagielloński, Wydział Biochemii, Biofizyki i Biotechnologii

Voivodeship: małopolskie

Other projects carried out by the institution »

Principal investigator (from the host institution)

dr hab. Agnieszka Wolnicka-Głubisz

Number of co-investigators in the project: 10

Call

OPUS 16 – announced on 2018-09-14

Amount awarded
1 456 500 PLN
Project start date
2019-07-05
Project end date
2024-07-04
Project duration
60 months (the same as in the proposal)
Project status
Project settled

Project description

Download the project description in a pdf file

Note — project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.

Information in the final report

Publication in academic press/journals (6)

  1. Rola białka RIPK4 w fizjologii naskórka.

    Authors:
    Madej Ewelina, Lisek Anna, Wolnicka-Głubisz Agnieszka
    Academic press:
    Postępy Biochemii (year: 2021, volume: 67, pages: 64-71), Publisher: Uniwersytet Warszawski
    Status:
    Published
    DOI:
    10.18388/pb.2021_370 – link to the publication
  2. RIPK4 downregulation impairs Wnt3A-stimulated invasiveness via Wnt/b-catenin signaling in melanoma cells and tumor growth in vivo

    Authors:
    Wroński Norbert, Madej Ewelina, Grabacka Maja, Brożyna Anna A., Wolnicka-Głubisz Agnieszka
    Academic press:
    Cellular Signalling (year: 2024, volume: 113, pages: 12), Publisher: Elsevier
    Status:
    Published
    DOI:
    10.1016/j.cellsig.2023.110938 – link to the publication
  3. Vemurafenib and Dabrafenib Downregulates RIPK4 Level

    Authors:
    Madej E, Brożyna AA, Adamczyk A, Wronski N, Harazin-Lechowska A, Muzyk A, Makuch K, Markiewicz M, Rys J, Wolnicka-Glubisz A.
    Academic press:
    Cancers (year: 2023, volume: 15, pages: 46045), Publisher: MDPI
    Status:
    Published
    DOI:
    10.3390/cancers15030918. – link to the publication
  4. Deciphering the functional role of RIPK4 in melanoma.

    Authors:
    Madej Ewelina, Ryszawy Damian, Brozyna Anna, Czyz Małgorzata, Czyz Jarosław, Wolnicka-Głubisz Agnieszka
    Academic press:
    International Journal of Molecular Sciences (year: 2021, volume: 22, pages: 11504), Publisher: MDPI
    Status:
    Published
    DOI:
    10.3390/ijms222111504 – link to the publication
  5. Downregulation Reduces ABCG2 Expression, Increasing BRAF-Mutated Melanoma Cell Susceptibility to Cisplatin- and Doxorubicin-Induced Apoptosis.

    Authors:
    Bartlomiej Olajossy; Norbert Wronski; Ewelina Madej; Joanna Komperda; Malgorzata Szczygiel; Agnieszka Wolnicka-Glubisz
    Academic press:
    Biomolecules (year: 2024, volume: brak, pages: 10), Publisher: MDPI
    Status:
    Published
    DOI:
    10.3390/biom14121573 – link to the publication
  6. The invlolvement of RIPK4 in TNF-α- stimulated IL-6 and IL-8 production by melanoma cells

    Authors:
    Ewelina Madej, Anna Lisek, Anna A. Brożyna, Agnieszka Cierniak, Norbert Wronski, Milena Deptula, Anna Wardowska, Agnieszka Wolnicka-Glubisz
    Academic press:
    Journal of Cancer Research and Clinical Oncology (year: 2024, volume: 150, pages: 46036), Publisher: Springer
    Status:
    Published
    DOI:
    10.1007/s00432-024-05732-3 – link to the publication

« New search

Graphic design and implementation: Jakub Piotrowski